Trials / Completed
CompletedNCT03095508
Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat
Prospective, Multicenter, Open, Randomized, Parallel, Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray [Menthol], 0,5 mg + 2 mg / 1 ml (Sandoz d.d., Slovenia), and ANTI-ANGIN® FORMULA, Topical Metered Spray, 0,12 mg + 0,24 mg / Dose (OOO "Valeant", Russia) in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 229 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate no less therapeutic efficacy and safety of the Angal S, topical spray \[Menthol\], 0,5 mg + 2 mg (Sandoz dd, Slovenia) compared to ANTI-ANGIN® FORMULA, topical metered spray, 0,12 mg + 0,24 mg (LLC "Valeant", Russia) in treatment of patients with uncomplicated acute infectious and inflammatory diseases of the pharynx, accompanied by a sore throat.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Angal S, topical spray [Menthol] | 0,5 mg + 2 mg (Sandoz d.d., Slovenia), administered as three to five consecutive presses on the actuator button, 6-10 times per day, for a maximum 4 days or until full illness resolution |
| DRUG | ANTI-ANGIN® FORMULA, topical metered spray | 0,12 mg + 0,24 mg (LLC "Valeant", Russia) administered as one to two consecutive presses on the actuator button, up to 6 times per day, , for a maximum 5 days or until full illness resolution |
Timeline
- Start date
- 2017-02-22
- Primary completion
- 2017-05-08
- Completion
- 2017-05-08
- First posted
- 2017-03-29
- Last updated
- 2019-03-21
- Results posted
- 2019-03-21
Locations
14 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT03095508. Inclusion in this directory is not an endorsement.